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Summary 
Trypanosoma cruzi invades most nucleated mamma- 
lian cells by as yet unknown mechanisms. We report 
here that while T. cruzi attaches to epithelial cells lack- 
ing signaling transforming growth factor p (TGFI~) re- 
ceptor I or II, the adherent parasites cannot penetrate 
and replicate inside the mutant cells, as they do in 
parental cells. Invasion of the mutants is restored by 
transfection with the TGFp receptor genes, as are bio- 
logical responses to TGFp. Similar rescue of both 
TGFp antiproliferative response and T. cruzi invasion 
was demonstrated in a hybrid of TGFl~-resistant blad- 
der and colon carcinoma cells. In addition, T. cruzi did 
not efficiently invade epithelial cells with dysfunction 
of the intracellular signaling cascade caused by the 
constitutive expression of the cyclin-dependent kinase 
cdk4 or of the oncogene H.ras. Treatment with TGFJ~, 
but not with other antiproliferative agents of non- 
phagocytic cells, greatly enhances T. cruzi invasion. 
Moreover, infective, but not noninfective, trypanosomes 
strongly induce a TGFp-responsive reporter gene in 
TGFI3-sensitive, but not in TGFp-insensitive, cell lines. 
Thus, T. cruzi itself may directly trigger activation of 
the TGFp signaling pathway required for parasite entry 
into the mammalian cells. 
Introduction 
Trypanosoma cruzi is an obligate intracellular parasite, 
causing a chronic debilitating illness, Chagas' disease, in 
millions of people in Latin America. It infects most cell 
types, including fibroblasts, epithelial cells, endothelial 
cells, myocytes, and macrophages. Trypomastigote, the 
infective form of T. cruzi, adheres to specific receptors on 
the outer membrane of host cells as a prelude to intracellu- 
lar invasion. Adhesion is mediated by at least two parasite 
ligands that react with carbohydrate receptor epitopes on 
the host cell surface (Pereira, 1994). One of the ligands 
is the trans-sialidase, which promotes attachment by re- 
acting with ~2,3-1inked sialyl epitopes, and the other is 
penetrin, which reacts with host cell receptors containing 
heparan sulfate moieties. 
Trypomastigote binding to the host cell surface does 
not, by itself, guarantee access of the parasite into the 
intracellular environment. In fact, it is possible to prevent 
adherent parasites from entering culture cells by blocking 
early metabolic responses that arise during host cell-para- 
site interactions (Tardieux et al., 1994; Moreno et al., 1994; 
Yakubu et al., 1994) and by altering lysosome traffic in 
the mammalian cells (Tardieux et al., 1992). 
T. cruzi invasion may therefore require activation of spe- 
cific signaling pathways critical for parasite entry into host 
cells. This hypothesis is consistent with current concepts 
of cellular invasion by virus and bacteria, which can acti- 
vate surface membrane signaling molecules in their inter- 
play with mammalian cell hosts (Gooding, 1992; Bliska et 
al., 1993). As an attempt o find the nature of these signal- 
ing pathways, we measured T. cruzi invasion of cell lines 
activated with various growth factors or genetically resis- 
tant to cytokine stimulation. We found that mink lung epi- 
thelial cells with a defect in the genes encoding signaling 
receptors I and II for transforming rowth factor 13 (TGFIS) 
were resistant to TGFI~ (Laiho et al., 1990; Wrana et al., 
1992) as well as to T. cruzi invasion. Although T. cruzi 
could not invade the mutant cells, they attached to them 
at the same or at higher levels than to parental cells. Trans- 
fection of the mutants with plasmids carrying wild-type 
receptor genes restored response both to TGF~ action 
and T. cruzi invasion. T. cruzi invasion of other cell lines 
is also consistent with a requirement for TGFJ3 signaling. 
This signaling pathway may be activated by a factor se- 
creted by infective trypomastigotes, as suggested by the 
results with a TGFI3-responsive reporter gene. 
TGFI3 induces signals in mammalian cells that lead to 
many types of biological activities, including regulation of 
cell proliferation and differentiation, extracellular matrix 
deposition, and modulation of many inflammatory and im- 
mune responses (Roberts and Sporn, 1990; Massagu~, 
1990; Miyazono et al., 1994). It is now apparent hat TGFI3 
signaling in nonphagocytic ells is subverted by a micro- 
bial invader to gain access into a privileged niche, the host 
cell cytoplasm. 
Results 
Epithelial Cell Mutants Lacking TGFI~ Receptor I 
or II Are Nonpermissive to T. cruzi Infection 
Mink lung epithelial cells resistant to TGFI3 action were 
originally isolated by chemical mutagenesis. One mutant 
phenotype, class R, expresses receptor II but not receptor 
I, while another phenotype, class DR, expresses receptor 
I but not receptor II (Laiho et al., 1990; Wrana et al., 1992). 
To determine whether the R phenotype was permissive 
to T. cruzi infection, we incubated mutant and parental 
cells (Mv1Lu) with various concentrations of trypomasti- 
gotes at 37°C for 2 days to allow differentiation into, and 
replication of, intracellular amastigotes (Pereira, 1990). 
Remarkably, R-1B cells were extremely resistant to T. 
cruzi infection in a wide range of parasite concentrations 
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Figure 1. Invasion of Parental and TIBR Mutant Cells by T. cruzi 
Infection of parental and mutant cells R-1 B (A) and parental and mutant 
cells DR-26 and DR-27 (B) with T. cruzi trypomastigotes. Cytology of 
the infection (40:1 ratio of T. cruzi to host cell) of parental MvlLu 
cells, R-1B cells, and R-1B cells transfected with ALK-5 gene (clone 
RIB-TR25) 2 days after start of infection (C). Please note in (C) the 
abundance of intracellular amastigotes in most parental and 
transfected R-1B cells, in contrast with the rarity of parasites found 
in mutant R-1B cells. Magnification, 295x. Results similar to those 
above were reproducible in at least eight other experiments. 
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Figure 2. Adhesion and Penetration of T. cruzi into Epithelial Cell 
Lines 
Adhesion (A) and penetration (B) of trypomastigotes to the indicated 
cell lines was determined as described in the Experimental Proce- 
dures. 
(Figures 1A and 1C). At the highest trypomastigote inocu- 
lure (2 x 106 parasites/monolayer), 43.1% _+ 10.7% of 
parental MvlLu cells were infected by T. cruzi compared 
with only 0.5% _ 0.1% for R-1B cells, representing >80- 
fold increase in resistance to infection in the R phenotype 
(Figures 1A and 1C). 
Two types of DR mutant cells (DR-26 and DR-27) were 
tested for their potential to be infected by T. cruzi. The 
TGFI3 receptor II (TI3R-II) in DR-26 cells contains a single 
base mutation that transforms the seventh codon of the 
transmembrane region into a stop codon, and the TI3R-II 
in DR-27 contains a single base mutation that converts 
the third cysteine of the extracellular domain to tyrosine 
(Wrana et al., 1992). The TI3R-I in both DR-26 and DR-27 
contains no mutation (Wrana et al., 1992). When these 
DR cell lines were tested for their potential to be infected by 
T. cruzi, they were found to be highly resistant o invasion 
(Figure 1B). 
T. cruzi Attaches to, but Cannot Penetrate, 
Epithelial Cells Expressing Defective 
TI]R-I or TI~R-II 
The resistance of R and DR mutants to being infected by 
T. cruzi could result from the inability of the parasites to 
attach to surface receptors, to enter the cells, orto differen- 
tiate and replicate intracellularly. To determine whether 
adherence was a mechanism of resistance, trypomasti- 
gotes were incubated with glutaraldehyde-fixed mono- 
layers of parental and mutant cells. These cells should 
allow binding but not invasion of the parasites (Ortega- 
Barria and Pereira, 1991). We found that T. cruzi attached 
to the mutant cells at levels similar to or higher than those 
supported by parental cells (Figure 2A). Therefore, the 
inability of T. cruzi to infect the TI3R mutant cells was not 
at the level of adhesion receptors. 
To determine whether the adherent parasites were ca- 
pable of penetrating the mutant cells, parasites were incu- 
bated with live monolayers of MvlLu, R, and DR cells for 
1 hr to allow attachment and entry. The monolayers were 
washed to remove unbound trypanosomes and fixed with 
glutaraldehyde, making the outer membrane imperme- 
able to macromolecules. In this way, residual extracellular 
parasites could be quantitated with polyclonal antibodies 
against T. cruzi, and intracellular and extracellular para- 
sites with DNA stains such as DAPI (Schenkman et al., 
1991). We found that trypomastigotes entered parental 
but not T~R mutant cells (Figure 2B). The inability of T. 
cruzi to grow in the R and DR mutants results, therefore, 
from a defect in penetration of the epithelial cells. Similar 
inability to penetrate was observed in the interaction of T. 
cruzi with TGF~-resistant colon (SW480) and bladder (EJ) 
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carcinoma cell lines (Figure 2B; Geiser et al., 1992; see 
below). A TGFI3-susceptible hybrid of the two cell lines 
(HYB-2) was more permissive to T. cruzi penetration than 
parental cells (Figure 2B). Moreover, T. cruzi did not effi- 
ciently enter a TGFl~-resistant H-ras-transformed rat cell 
line (IEC-ras7) (Figure 2B), whereas it invaded the TGFJ3- 
sensitive parental IEC-18 cells (Figure 2B; Filmus et al., 
1992; see below). 
Restoration of Permissiveness to T. cruzi Infection 
by Transformation with TJ~R Genes 
To assess the ability of signaling TI~Rs to mediate T. cruzi 
invasion, we stably transfected DR-27 cells with a human 
TI3R-II cDNA (Lin et al., 1992). Remarkably, transfected 
DR-27 cells became permissive hosts for T. cruzi invasion 
at levels comparable to those of wild-type Mv1Lu (Table 
1). This confirmed that the nonpermissiveness of DR-27 
cells was due to a defect in their signaling pathway at 
the level of the TI3Rs. The transfectant clones expressed 
human TI3R-II on their surface because TGFI31 inhibited 
[aH]thymidine incorporation into DNA of the growing cells 
in response to TGFI3 (Figure 3A). To prove this point fur- 
ther, the transfectants were treated with radioiodinated 
TGFI31 and incubated with the chemical cross-linker disuc- 
cinimidyl suberate to label the TI3Rs (Massagu~, 1987). 
The labeled receptors were then resolved by SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE) and visual- 
ized by autoradiography. While the DR-27 mutant showed 
a concomitant loss of receptors I and II, the transfectant 
clones showed a normal receptor labeling pattern (Figure 
3B) as in reported results (Wrana et al., 1992). 
Likewise, transfection of resistant R-1 B cells with TI3R-I 
gene (ALK-5) (Franzen et al., 1993) restored T. cruzi inva- 
sion to levels comparable to those of parental cells (Figure 
1C). Transfected R-1B clones, such as R-1 B-TR25 shown 
in Figure 1C, were growth arrested by TGFI31 in a kinetics 
and dose response similar to that with parental MvlLu 
cells (M. M. and M. E. A. P., unpublished data). 
Table 1. Transformation of DR-27 Mutant Cells with a Plasmid 
Encoding the Human T~R-II Gene Restored Permissiveness 
to T. cruzi Infection 
Infection (%) 4- SD b 
Trypomastigote Inoculum" 
(Parasites/200 #1) x 104 Mv1Lu DR-27 DR27-TR47 ~ 
0.8 0.3 4- 0.0 0.0 4- 0.0 0.1 4- 0.0 
3.1 1.6 4- 0.4 0.1 4- 0.0 0.g 4- 0.0 
12.5 7.0 4- 1.0 0.6 4- 0.0 5.7 4- 0.7 
50.0 24.5 4- 4.2 0.9 4- 0.0 15.8 4- 2.6 
200.0 32.3 4- 2.3 4.9 4- 1.1 26.2 4- 1.1 
Cell lines were incubated with theindicated concentrations ofT. cruzi 
for I hr and, after removing u bound parasites by washing, they were 
further incubated at 37° C for 3 days. Infection was quantitated by 
determining the percentage of cells containing more than two amasti- 
gotes. Results are representative of three others and epresent an 
average of quadruplicate points. 
MvlLu is the parental cell line of mutant DR-27, which lacks TI3R-II; 
DR27-47 is the DR-27 mutant transfected with a plasmid encoding 
TI3R-II (see Figure 3). 
c Similar results were obtained with the transfectant DR27-TR50 (see 
text). 
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Figure 3. Characteristics of the Parental Mv1Lu, Mutant DR-27, and 
DR-27 Clones (DR27-TR47 and DR27-TR50) Transfected with Human 
T[3R-II 
(A) Inhibition of DNA synthesis by TGFI31. Subconfluent monolayers 
of the various cell lines were incubated for 48 hr with the indicated 
concentrations ofTGFI~I and then for 18 hr with [3H]thymidine. Results 
are plotted as percent inhibition of the [3H]thymidine incorporation of
cells grown in the absence of TGF~I. Each point is the average of 
quadruplicate samples, and standard deviation was less than 50. 
(B) Cross-linking of [12Sl]TGFI31 to MvlLu, DR-27, and DR-27 cells 
transfected with human TI3R-II. Cells were incubated with 50 pM 
[12q]TGFI31 and cross-linked with disuccinimidyl suberate before analy- 
sis by SDS-PAGE as described in the Experimental Procedures. 
Lanes a and b, MvlLu cells; lanes c and d, DR-27 cells; lanes e and 
f, transfectant DR27-TR47; lanes g and h, transfeotant DR27-TR50. 
Lanes a, c, e, and g represent one experiment, and lanes b, d, f, and 
h represent another experiment. The three types of T~Rs are indicated 
by arrows on the left (BG, 13-glycan or receptor Ill). 
Activation of Mammalian Cells with TGFpl 
Enhances Infection in a Specific Manner 
The above results suggest that the TI3Rs are required for 
T. cruzi invasion. This opens the possibility that signaling 
through the receptors directs parasite invasion. As a first 
approach to investigate this possibility, we asked whether 
activation of the receptors facilitated T. cruzi invasion. For 
this, Mv1Lu cells were treated with TGFI31 (1.0 ng/ml) for 
2, 8, and 24 hr, washed to remove residual cytokine, and 
assayed for their ability to be infected by T. cruzi. The 
results show that TGF~l-primed cells supported T. cruzi 
infection much more efficiently than nonsensitized cells 
(Figure 4A). Similar increase in infection was obtained by 
priming Mv1Lu cells with another isoform of TGF~, TGFJ32 
(data not shown). The rise in infection resulting from the 
sensitization with TGF~ required signal transduction 
through the T~Rs because DR-27 cells did not become a 
better host after priming with TGFI~ (Figure 4A). Further- 
more, clones of DR-27 transfected with TI3R-II behave like 
parental cells upon sensitization with TGF~I (Figure 4A). 
Sensitization with epidermal growth factor (EGF) and 
platelet-derived growth factor (PDGF) did not affect T. 
cruzi invasion (data not shown). 
TGFI3-activated cells did not become more permissive 
to another intracellular protozoan parasite, Toxoplasma 
gondii (Figure 4B), which resides inside cytoplasmic vesi- 
cles of a variety of mammalian cells (Schwab et al., 1994). 
Furthermore, T. gondii invaded DR-27 cells to the same 
extent as parental mink lung cells (Figure 4B). Thus, the 
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Figure 4. Specific Enhancement ofT. cruzi Infection by TGFI~ Sensiti- 
zation of Epithelial Cells 
(A) Parental Mvl Lu, mutant DR-27, and stable transfectants DR27- 
TR47 and DR27-TR50 were grown in the absence (control) or in the 
presence of TGFp,1 (2 ng/ml) for the indicated times and infected with 
T. cruzi (1 x 10 s trypomastigotes/well for 2 hr, washed, and then 
further incubated for 2 days at 37°C). 
(B) Parental and DR-27 cells without priming (control) or primed with 
TGFI31 (1 ng/ml, 24 hr) were infected with T. gondii for 2 days. 
(C) MvlLu cells were grown for 24 hr in the absence (control) or in 
the presence of the indicated concentrations ofTGF~I, rapamycin, 
and a cAMP analog (Bt2cAMP), and then infected with T. cruzi for 2 
days as in (A). 
Cell cycle distribution ofsubeonfluent Mvl Lu cells treated with rapa- 
mycin (40 ng/ml for 21 hr) was as follows: G1 = 93.0%, S = 6.3%, 
and G2/M = 0.7%, compared with G1 = 48.8%, S = 16.9%, and 
G2/M = 34.3% for the control cells not treated with rapamycin. 
increase in invasion by activation with TGFI3 may be spe- 
cific for T. cruzi. 
MvlLu cells treated with TGFI31 under the conditions 
described in Figure 4 are arrested at mid- to late-G1 phase 
of the cell cycle (Massagu6, 1990). To determine whether 
the increased susceptibility to T. cruzi infection was a di- 
rect consequence of the G1 arrest, regardless of the cellu- 
lar stimulus, we treated MvlLu cells with cyclic AMP 
(cAMP) or rapamycin for 24 hr prior to using them as host 
for T. cruzi. Under these conditions, cAMP arrests cell 
growth at G1 and G2 (Boynton and Whitfield, 1983; 
M. E. E., unpublished ata) and rapamycin only at G 1 (see 
legend to Figure 4C). Treatment of MvlLu cells with a 
cAMP analog or with rapamycin did not significantly in- 
crease T. cruzi invasion, compared with the sharp rise 
induced by TGFI31 sensitization (Figure 4C). Because 
priming with rapamycin, which arrests the cell cycle at 
G1, and with the growth factors EGF and PDGF, which 
stimulate cell multiplication, did not enhance invasion of 
T. cruzi, the enhancement in TGFI3-activated Mvl Lu cells 
appeared to be specific for the antiproliferative cytokine. 
Moreover, TGFI31 priming of monkey fibroblasts (Vero 
cells) and bovine endothelial cells enhanced T. cruzi infec- 
tion significantly, and the enhancement was blocked by 
TGFl~-neutralizing antibodies (M. M. and M. E. A. P., un- 
published data), suggesting that T. cruzi may use the 
TGFI3 signaling pathway to invade a variety of cell types. 
However, TGFl3-activated human or mouse macrophages 
did not become better hosts for T. cruzi (M. M. and 
M. E. A. P., unpublished ata), suggesting that the TGFI3 
signaling pathway may not be critical for T. cruzi invasion 
of phagocytic cells. 
Restoration of T. cruzi Invasion in a Hybrid of Two 
Nonresponsive Human Carcinoma Cell Lines 
Further evidence that efficient T. cruzi invasion of host 
cells requires TGFI3 signaling was provided by the re- 
sponse of a hybrid of two TGFl3-resistant human carci- 
noma cell lines. Previous studies showed that this hybrid 
cell line expresses much higher levels of surface TISR-II 
than parental EJ bladder carcinoma and the SW480 colon 
adenocarcinorna cells (Geiser et al., 1992). Consequently, 
the cell hybrid, but not the parental cell lines, is growth 
arrested in response to TGFI~ (Figure 5A) (Geiser et al., 
1992). When these cell lines were tested for permis- 
siveness to T. cruzi invasion, the difference in host poten- 
tial between the TGFI3-resistant carcinoma cells and a 
TGF~-sensitive hybrid (HYB-2) cell line was very dramatic 
indeed (Figures 2B, 5B, and 5C). As already discussed 
above, trypomastigotes penetrated TGFl~-resistant paren- 
tal carcinoma cells inefficiently compared with their inva- 
sion of the TG Fl~-sensitive hybrid (Figure 2B). Moreover, T. 
cruzi infected poorly (less than 10%) parental carcinoma 
cells and robustly (nearly 80%) HYB-2 cells (Figures 5B 
and 5C). Furthermore, T. cruzi infected nearly all TGFI3- 
activated HYB-2 cells and only about 10% of TGFIB- 
activated parental carcinoma cells (Figure 5B). These find- 
ings further underscore the critical role of TGFI3 signaling 
in promoting T. cruzi invasion of mammalian cells. 
Constitutive Expression of the Cyclin-Dependent 
Kinase Cdk4 or Transformation with the 
Oncogene H-ras Renders Epithelial Cells Resistant 
to Both TGFp Activation and T. cruzi Invasion 
Normal progression through the G1 phase of the cell cycle 
is promoted by the activity of the cyclin-dependent protein 
kinases cdk2 and cdk4 (Sherr, 1993). In mink lung cells, 
TGFI~ inhibits cellular proliferation largely by down-regu- 
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Figure 5. Response of EJ Bladder Carcinoma Cells, ofSW480 Colon 
Carci noma Cells, and ofa Hybrid of the Two Carcinoma Cells to TG FI31 
and T. cruzi 
(A) Inhibition of DNA synthesis in the three types of cell lines grown 
in the presence of the indicated concentrations f TGF~I. 
(B) T. cruzi infection of the three cell lines without (control) and with 
TGFI~I priming (2 ng/ml, 24 hr). After priming or mock priming (absence 
of TGF~I), cells were washed and infected with T. cruzi for 2 days. 
(C) Fluorescence microscopy of E J, SW480, and hybrid cell line HYB-2 
infected with T. cruzi. Two days after infection, monolayers were fixed 
with formaldehyde and permeabilized with 0.1% Triton X-100, and the 
parasites (amastigotes) were visualized by indirect immunofluores- 
cence (first antibody, IgG from chronic Chagasic patients; second anti- 
body, an FITC-labeled rabbit anti-human IgG). Please note abundant 
intracellular fluorescent amastigotes in most of the HYB-2 cells, in 
contrast with the paucity of parasites in the parental carcinoma cells. 
Magnification, 295 x. 
These experiments were repeated more than four times with similar 
results• 
lating the activity of cdk2 and cdk4 kinases (Ewen et al., 
1993; Koff et al., 1993). TGFI3 inactivates cdk4 directly by 
decreasing the level of cdk4 expression, and constitutive 
expression of cdk4 turns Mvl Lu cells resistant to the ef- 
fects of TGFI31 (Ewen et al., 1993). We tested the permis- 
siveness to T. cruzi invasion of the MvlLu-derived cdk4 
clone (B7), which expresses cdk4 constitutively at rela- 
tively high levels (Ewen et al., 1993). Remarkably, this 
Mvl Lu-cdk4 clone was not only resistant o T. cruzi inva- 
sion, but their low permissiveness was not significantly 
enhanced by TGFI32 priming, contrary to the steep rise in 
T. cruzi invasion of TGFI3-sensitized parental cells (Fig- 
ure 6A). 
Another type of intracellular dysfunction that confers re- 
sistance to TGFI3 results from overexpression of the acti- 
vated human oncogene H-ras (Filmus et al., 1992). As 
already discussed, the rat intestinal cell IEC-18 is growth 
arrested by TGFI3, but after transformation with H-ras, it 
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Figure 6. Cell Lines Overexpressing Cdk4 kinase or H-ras Oncogene 
Are Nonpermissive to T. cruzi Invasion 
(A) Parental MvlLu cells and cdk4-B7 clone (overexpressing cdk4 
kinase) were grown with TGFI~2 (2 ng/ml) for the indicated times, and 
then infected with T. cruzi for 2 days. 
(B) Rat intestinal IEC cells and a IEC-ras7 clone (overexpressing H-ras 
oncogene) were grown in the absence (control) and presence of TGF!31 
(2 ng/ml) for 24 hr, and then infected with T. cruzi for 2 days. 
may become insensitive to the growth factor (Filmus et 
al., 1992). We found that parental, TGFI3-sensitive IEC-18 
cells were invaded by T. cruzi in a TGFl~-enhanceable 
manner, whereas an H-ras-transformed, TGFI3-resistant 
derivative of IEC-18 cells (IEC-ras7 clone) was not (Figure 
6B). Resistance to infection was due to a defect in T. cruzi 
penetration of TGFI3-resistant IEC-ras7 (Figure 2B). Thus, 
because cdk4 clone and IEC-ras7 cells express normal 
TGFI3 surface receptors (Ewen et al., 1993; Filmus et al., 
1992), the results with the cdk4 and H-ras clones indicate 
that T. cruzi invasion of epithelial cells requires intact 
TGFI3 signaling pathway and not just the availability of 
functional TI3Rs. 
Invasive, but Not Noninvasive, T. cruzi and 
Parasite Conditioned Medium Activate 
a TGFl~-Responsive Reporter Gene 
The above results suggest that downstream signaling pro- 
teins are important for T. cruzi invasion. To test the possi- 
bility that T. cruzi directly activates signal transduction 
through the TI3Rs, we incubated live parasites with mono- 
layers of Mv1 Lu cells stably transfected with a plasmino- 
gen activator inhibitor-1 (PAl-l) construct (Abe et al., 
1994). The construct is a plasmid containing a truncated 
PAl- 1 promoter fused to the firefly luciferase reporter gene. 
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Transfected cells increase luciferase activity to a great 
extent after stimulation with TG FI~, but minimallywith other 
inducers of PAl-1 expression and growth factors (Abe et 
al., 1994). We found that invasive trypomastigotes induced 
luciferase activity in transfected MvlLu cells in a dose- 
dependent manner, whereas noninvasive epimastigotes 
had no effect (Figure 7A). PAl-1 promoter activation by live 
trypomastigotes was also de monstrated in cells transiently 
transfected with another PAl-1 promoter-luciferase con- 
struct, p3TP-Lux (Wrana et al., 1992; data not shown). 
We then determined whether proteins shed by T. cruzi 
would contain the PAl-1 promoter activator. For this, we 
prepared an extract of live parasites by incubating them 
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Figure 7. Transcriptional Activation of PAl-1 Promoter Constructs by 
T. cruzi 
(A) Induction of luciferase in MvlLu cells stably transfected with a 
PA/-7-1uciferase construct. Monolayers were treated with the indicated 
concentrations ofTGF~I or live trypomastigotes (Tryps) and epimasti- 
gotes (Epi). Luciferase activity (relative light units or RLU) in the cell 
lysates was determined ina luminometer 20 hr after addition of TGFI~I 
or parasites. 
(B) Restoration of responsiveness toTGFI3 and T. cruzi n two classes 
of TGFI3-resistant cells by transient transfection with human T~R-II 
and T~R-I. Transfectants consisted of the PAkl construct, p3TP-Lux 
in the cell lines Mvl Lu, DR-27, and R-1 B, as indicated in the abscissa. 
Cotransfectants consisted of p3TP-Lux plus empty pCDNA I in DR-27 
(DR27-vector), p3TP-Lux plus kinase-deficient T~R-II in DR-27 cells 
(DR27-K277R), p3TP-Lux plus human T~R-II in DR-27 cells (DR-27- 
T~RII), and p3TP-Lux plus human TI~R-I in R-1B cells (R1B-ALK5). 
Luciferase activity was determined incell monolayers that had been 
incubated for 20 hr in the absence (control) and in the presence of the 
indicated concentrations of TGF~I and trypomastigote extract (Trypo 
extract) and epimastigote extract (Epi extract). 
(C) Lack of PAl-1 promoter activation by trans-sialidase and penetrin. 
Mvl Lu cells transiently transfected with p3TP-Lux were grown in the 
absence (control) and in the presence of the indicated concentrations 
of trypomastigote extract (Tryp, in pg/ml), purified trans-sialidase (TS, 
in ng/ml), penetrin (PN, in p.g/ml), and TGFI~I (in ng/ml). Note that TS 
and PN did not induce PAl-1 response while the induction of the PAl-1 
promoter by the trypomastigote extract in this experiment was even 
greater than that in the experiment shown in (B). 
at 4°C for 2 days in RPMI medium containing a cocktail of 
protease inhibitors followed by centrifugation and filtration 
through 0.22 I~m pores. This cell-free RPMI extract con- 
tains mostly surface and secreted proteins (Cavallesco 
and Pereira, 1988). Remarkably, extract from invasive try- 
pomastigotes, but not from noninvasive pimastigotes (4 
and 8 i~g/ml), induced luciferase activity to a great extent 
(Figure 7B). 
Unequivocal demonstration that T. cruzi activates the 
TIeR signaling pathway was provided with DR and R mu- 
tant cells transiently transfected with p3TP-Lux. Neither 
TG FI31 nor the trypomastigote extract activated the PAl-1 
promoter in DR-27 and R-1B cells (Figure 7B). However, 
when DR-27 cells and R-1 B cells were transiently cotrans- 
fected with p3TP-Lux and with plasmids containing T~R-II 
or TI~R-I genes, respectively, they produced high lucifer- 
ase activity upon stimulation with either TGFI[}I or trypo- 
mastigote xtract, but not with epimastigote xtract (Fig- 
ure 7B). Cotransfection of DR-27 mutants with p3TP-Lux 
plus empty pcDNA I (Figure 7B, DR27-vector) or with a 
plasmid containing a kinase-deficient receptor II construct 
(Chen and Weinberg, 1995; Figure 7B, DR27-K277R) did 
not produce promoter esponse to TGFI31 nor to T. cruzi. 
Like TGFI3, which inhibits DNA synthesis and cell prolifera- 
tion in many cell types (Massagu~, 1990), trypomastigote 
extract inhibited DNA synthesis ([3H]thymidine incorpora- 
tion) in TGFI3-responsive Mv1Lu cells but not in TGFI3- 
resistant DR-27 and R-1B cells (data not shown). Noninva- 
sive epimastigotes did not inhibit DNA synthesis in Mvl Lu 
cells. These results further confirm the stimulation of the 
TGFI3 signaling pathway by T. cruzi. This stimulation was 
selective for T. cruzi because a similar extract from two 
other protozoan parasites, Plasmodium falciparum ( -  108 
trophozoites plus schizont stages/ml) and T. gondii ( -  108 
tissue culture forms/ml), did not activate the PAl-1 pro- 
moter (M. M. and M. E. A. P., unpublished data). 
Trans-sialidase and penetrin are surface proteins impli- 
cated in parasite adhesion to mammalian cells (Pereira, 
1994). Because these proteins are present in the trypo- 
mastigote extract, it is possible that they will bind to cell 
surface sialyl and heparan sulfate epitopes and activate 
the TGFI3 signaling pathway. However, purified trans- 
sialidase, at concentrations imilar to those in the trypo- 
mastigote xtract, did not trigger PAl-1 promoter esponse 
in transiently transfected Mv1 Lu cells (Figure 7C), nor did 
purified penetrin at relatively high concentrations (Fig- 
ure 7C). 
We have partially purified the TGFl~-Iike factor from try- 
pomastigote extracts through several steps of conven- 
tional protein fractionation procedures. The factor did not 
react with a variety of commercial TGFI3 monoclonal and 
polyclonal antibodies, as determined by neutralization of 
biological activity, immunoblot, and ELISA (M. M. and 
M. E. A. P., unpublished data). 
Discussion 
TGFI3 is a cytokine that alters many functions in nearly all 
higher eukaryotic cells (Roberts and Sporn, 1990). The 
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nature of the TGFI3 action depends on many parameters, 
including type and state of differentiation of the cell tar- 
gets, growth conditions, and presence of other growth fac- 
tors. TGFI3 controls extracellular matrix production, regu- 
lation of myogenesis, immune response, angiogenesis, 
and embryogenesis. Here, we report that utilization of the 
TGFI3 signaling pathway by a pathogenic microbe is es- 
sential for the invader to gain access and thrive in the 
cytosol of nonphagocytic host cells. 
Many types of evidence support the hypothesis that T. 
cruzi invasion requires activation of the TGFI3 signaling 
pathway. T. cruzi could not infect, or infected extremely 
inefficiently, m ink lung epithelial cells with a genetic defect 
in TI3R-I or TI3R-II (Figures 1A and 1B). Reconstitution of 
TI3R function by transfection with human receptor I or II 
restored sensitivity of the mutants to TGFI3 and permis- 
siveness to T. cruzi invasion (Figure 1C; Table 1). Simi- 
larly, T. cruzi did not efficiently invade the human EJ blad- 
der carcinoma cell line nor the human SW480 colon 
adenocarcinoma cells (Figure 5B). These cells express 
relatively low levels of TI3R-II and thus are resistant to 
TGFI3-induced growth arrest (Figure 5A; Geiser et al., 
1992). However, fusion of EJ cells with SW480 cells pro- 
duced a hybrid cell sensitive to TGFI3 due to high level 
expression of receptor II (Figure 5A; Geiser et al., 1992). 
Rescue of TGFI3 response in the hybrid cell line correlated 
with a remarkable permissiveness to T. cruzi invasion (Fig- 
ure 5B). Another approach to demonstrate the importance 
of the TGFI3 signaling for T. cruzi invasion was to infect 
cells genetically engineered to constitutively overexpress 
cdk4 kinase and H-ras oncogene, which make them 
growth resistant to TGFI3 (Ewen et al., 1993; Filmus et 
al., i992). Consistent with the other results summarized 
above, mink and rat epithelial cells with deregulated cdk4 
and H-ras expression were very poor hosts for T. cruzi 
(Figures 6A and 6B). 
The conclusion from these genetic studies was consis- 
tent with the enhanced T. cruzi invasion of TGFl~-sensi- 
tized wild-type cells from different animal species and of 
various lineages (Figure 4A; unpublished data). Enhance- 
ment of invasion was specific for TGFI~, since priming of 
the cells with other growth factors (EGF and PDGF) and 
with molecules capable of eliciting a G1 growth arrest (ra- 
pamycin and cAMP) did not increase invasion. 
Our findings are consistent with early studies demon- 
strating a dependency of T. cruzi invasion on the phase 
of the host cell cycle. Specifically, T. cruzi invasion of syn- 
chronized cultured cells increased as the cells progressed 
from G1 to the S phase of the cell cycle and dropped 
sharply as the cells entered G2/M (Dvorak and Crane, 
1981). According ly, Mvl Lu and other cells arrested at mid- 
to late-G1 by TGFI3 (Massagu6, 1990) were much better 
hosts for T. cruzi than asynchronous culture cells (Figure 
4). However, cell arrest at G1 per se did not necessarily 
lead to enhanced trypanosome invasion, as suggested by 
the results with rapamycin, which blocks cells such as 
Mvl Lu at G1 (see legend to Figure 4C), through a mecha- 
nism distinct from the TGFI3 arrest (Kato et al., 1994). In 
addition, cells growth arrested at GO/G1 by contact inhibi- 
tion are much poorer hosts for T. cruzi than subconfluent 
cells progressing through the cell cycle (Henriquez et al., 
1981; Dvorak and Crane, 1981). Thus, contrary to the 
TGFI3 arrest, contact inhibition and rapamycin-induced G1 
block did not turn the cells into better hosts for T. cruzi, 
underscoring the specificity of the TGFI3 signaling path- 
way in directing trypanosome invasion. 
Our results also provide a logical explanation for early 
observations about the effect of T. cruzi and TGFI3 on 
skeletal muscle differentiation. Thus, T. cruzi infection of 
L6E9 rat myoblasts prevented the myoblasts from fusing 
into multinucleated myotubes (Rowin et al., 1983), an ef- 
fect similar to that of pu rifled TG FI3 (Massagu6 et al., 1986). 
Furthermore, T. cruzi reduced the expression of muscle- 
specific mRNA (Rowin et al., 1983), as did TGFI3 (Mas- 
sague et al, 1986). Moreover, the L6E9 cells, once commit- 
ted to myogenic differentiation, became resistant o the 
inhibitory effect of both T. cruzi and TGFI~, even though 
the differentiated cells were still able to be infected by 
T. cruzi and to be bound by TGFI~ (Rowin et al., 1983; 
Massagu6 et al., 1986). Thus, in view of the parallel actions 
of T. cruzi and TGFI3 on skeletal muscle differentiation in 
vitro, we hypothesize that the parasite-induced inhibition 
of myogenic differentiation results from trypomastigote ac- 
tivation of TIeRs. 
If T. cruzi invasion requires activation of the TGFI3 signal- 
ing pathway, then what turns the pathway on, the host 
TGFI3, the parasite-specified TGFI3-1ike factor, or both? 
Previous studies suggest that spleen cells from mice with 
acute T. cruzi infections produced elevated levels of TGFI3 
in vitro (Silva et al., 1991). This elevation could result from 
T. cruzi activating host-derived TGFI~ precursor into the 
active 25 kDa peptide. Other studies showed that prote- 
ases and sialidases can process the TGFI3 precursor into 
the active peptide (Miyazono and Heldin, 1989). Interest- 
ingly, T. cruzi secretes both protease (Cazzulo et al., 1989) 
and sialidase (Pereira, 1983) proteins. Therefore, the intri- 
guing possibility that T. cruzi can correctly process host 
TGFI3 precursor molecules should be further investigated. 
On the other hand, we found that T. cruzi itself, specifi- 
cally its invasive trypomastigote form, activates a TGFI3- 
responsive extracellular matrix protein (PAl-l) promoter 
of transfected Mvl Lu epithelial cells (Figure 7; Abe et al., 
1994). Trypomastigotes release a factor that engages the 
TGFI3 signaling receptors, as judged by the activation of 
another PAl-1 promoter construct (p3TP-Lux) in MvlLu 
cells (Wrana et al., 1992) by soluble proteins shed by inva- 
sive trypomastigotes. This T. cruzi-derived TGFI3-1ike fac- 
tor is distinct from host TGFI3 by many criteria, including 
physical properties like resistance to boiling (30 min at 
100°C; M. M. and M. E. A. P., unpublished data). Thus, 
it may also be that T. cruzi invasion is directed by a para- 
site-specified product that activates the TGFI~ signaling 
pathway. 
It is becoming evident that intracellular microbes can 
bind to cell surface receptor signaling proteins during their 
interaction with host cells. The bovine papilloma virus pro- 
tein E5 dimerizes in the plasma membrane, activates re- 
ceptors for several growth factors (Petti and DiMaio, 1992), 
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and binds to a vacuolar H+-ATPase to affect receptor re- 
cycling (Goldstein et al., 1991). The Epstein-Barr virus 
transforming protein LMP1 engages signaling proteins 
coupled to the tumor necrosis factor receptor family (Mo- 
sialos et al., 1995), and the HIV virus binds to CD4 recep- 
tors on lymphocytes as a requirement o invasion (Olshev- 
sky et al., 1990). These and other interactions (Gooding, 
1992) may be important not only in facilitating parasite 
growth but also in allowing the virally infected cells to 
evade cellular host defense mechanisms. Identification 
of relevant parasite ligands and characterization of the 
cellular changes induced by l igand-host cell interactions 
is an exciting and flourishing area of current microbiologi- 
cal research (Bliska et al., 1993). 
On the basis of the results presented here and else- 
where (Pereira, 1994), we propose that T. cruzi invasion 
starts with trypomastigotes attaching to host cells through 
at least two pathways involving trans-sialidase/sialic acid 
and penetrinlheparan sulfate recognition. These protein- 
carbohydrate interactions do not induce cellular invasion, 
which, at least in cells growth arrested by TGFI3, is driven 
by the activation of the TGFI3 signaling pathway through 
ligands distinct from trans-sialidase and penetrin. TGFI3 
signaling may be turned on either by host TGF~, by a 
TGFI3-1ike peptide released into the environment by the 
invading trypomastigotes, or by both. It will be of great 
interest to determine the mechanism used by T. cruzi to 
trigger TGFI~ signaling, whether that is the pathway that 
leads to G1 arrest, the pathway that induces extracellular 
matrix deposition, or both. It is likely that activation of the 
antiproliferative pathway is a requirement for invasion, as 
judged by the correlation between TGF~-induced inhibi- 
tion of DNA synthesis in various mammalian cell types 
and T. cruzi invasion. On the other hand, T. cruzi and T. 
cruzi extracts strongly activate a promoter for an extracel- 
lular matrix protein (Figure 7), suggesting that this pathway 
may be activated as well. Ascertaining these problems 
are not just of academic interest, for a T. cruzi-specified 
activation of the TGFI3 pathway might underlie responses 
such as immunosuppression (Wahl et al., 1988) and abnor- 
mal extracellular matrix deposition (Border and Ruoslahti, 
1992), each a dominant feature in humans and experimen- 
tal animals with acute (Brener and Krettli, 1990) and 
chronic Chagas' disease (Koberle, 1968; Andrade, 1983), 
respectively. 
Experimental Procedures 
Parasites 
The Silvio X-10/4 and Tulahuen clones of T. cruzi were obtained by 
infection of cultured Vero cells as previously described (Cavallesco 
and Pereira, 1988). The T. cruzi cell-free RPMI extract was obtained 
by incubating trypomastigotes and epimastigotes (from LIT medium) 
(2 x 10S/ml)for2 daysat4°CinRPMIcontainingacocktailofprotease 
inhibitors (10 p_M pepstatin A, 10 p.M leupeptin, 10 mU/ml aprotinin, 
5 mM EDTA, and 10 mM iodoacetamide), centrifuging the suspension 
(1000 x g, 10 min), and filtering the supernatant hrough 0.22 ~m 
pores. A RPMI extract of human red blood cells infected with P. falci- 
pa[um (containing a mixture of schizonts and trophozoites at -10el 
ml) was obtained in a manner similar to that of T. cruzi (gift from Drs. 
G. Pasvol and B. Clough). 
Cell Lines and Cell Culture 
The MvlLu mink lung cell line was from the ATCC (CCL-64), and the 
Mv1Lu-derived T~R mutants DR-26, DR-27, and R-1B were provided 
by Dr. J. Massagu~ (Laiho et al., 1990; Wrana et al., 1992). The SW480 
colon adenocarcinoma cell line was from ATCC (through Dr. J. 
Sharon), and the EJ bladder carcinoma cell line and the hybrid (HYB-2) 
of SW480 with EJ cells were provided by Dr. A. Geiser (Geiser et al., 
1992). The rat intestinal cell line IEC-18 and an IEC-18 clone trans- 
formed with human H-ras oncogene (IEC-ras7) were provided by Dr. 
J. Filmus (Filmus et al., 1992). The cdk4 B7 clone was the cell line 
used in previous tudies (Ewen et al., 1993). Cell lines were maintained 
as described in the references cited above. 
Infection Assay 
Infection of culture cells was carried out as described previously (Ca- 
vallesco and Pereira, 1988). Subconfluent monolayers were incubated 
for 1-2 hr at 37°C with various concentrations of trypomastigotes in
0.1 ml of RPMI-BSA, washed with RPMI to remove swimming para- 
sites, and further incubated for 2-3 days at 37°C in RPMI-1640 con- 
taining 5% FCS. Diff-Quik-stained preparations were examined under 
a microscope to estimate the ratio of infected (i.e., cells containing 
more than one intracellular amastigote) to noninfected cells. 
A similar protocol was used to infect monolayers with T. gondii, RH 
strain, provided by Dr. K. Joiner (Schwab et al., 1994). 
Adhesion Assay 
Adhesion of trypomastigotes to monolayers of glutaraldehyde-fixed 
cells was performed as previously described (Ortega-Barria nd Per- 
eira, 1991; Ming et al., 1993). In brief, trypomastigotes (lO~lwelllO.1 
ml of RPMI-BSA) were incubated at 37°C with glutaraldehyde-fixed 
monolayers in 16-well Lab-Tek chamber slides. After 1 hr, swimming 
and loosely bound parasites were removed by dipping the slides 10 
times in PBS. Adherent parasites were fixed for 10 rain with 4% para- 
formaldehyde in PBS containing 7% sucrose. After rinsing with PBS, 
the slides were stained with Diff-Quik and examined under a light 
microscope to assess T. cruzi adherence. A minimum of 300 host cells 
were counted for each point. 
Penetration Assay 
Monolayers of the various cell types, equilibrated in RPMI-BSA me- 
dium, were incubated with trypomastigotes (6 x 106/ml) for 1 hr at 
37°C, washed in cold HEPES-buffered (pH 7.2) RPMI, fixed in 2o/0 
paraformaldehyde in 100 mM lysine for 20 min, and blocked with 50 
mM ethanolamine (Schenkman et al., 1991). The monolayers were 
fixed one more time in 1% glutaraldehyde for 1 hr at room temperature 
and blocked with 1% BSA overnight at 4°C. The monolayers were 
then reacted for 30 min with IgG (20 p.g/ml) purified from human Cha- 
gasic sera (Cavallesco and Pereira, 1988) and washed several times 
with PBS, and the bound IgG were detected with an FITC-labeled 
second antibody (Sigma). After washing with PBS, the DNA of the 
host cells and the parasites was stained with DAPI (Sigma) at 5 p.g/ 
ml and observed under a Nikon epifluorescence microscope. 
Receptor Affinity-Labeling Assay 
These assays were performed precisely as described by Massagu~ 
(1987), except that [1251]TGFI31 (specific activity 137 tLCi/p~g) was from 
a commercial supplier (Dupont-New England Nuclear). 
Growth Inhibition Assay 
Cells were seeded in 96-well flat-bottomed plates, grown overnight at 
37°C in 10% FCS in RPMI, and incubated with various concentrations 
of recombinant human TGF~t (R & D Systems) or TGFI32 (Genzyme), 
EGF or PDGF (R & D Systems), BtcAMP (Sigma), rapamycin, or T. 
cruzi RPMI extract. After 2 days, cells were labeled with 1 ~Ci/ml 
[3H]thymidine (specific activity 16.8 Ci/mmol; Dupont-New England 
Nuclear) for 18 hr, washed three times with cold PBS, extracted with 
0.2 N NaOH for 30 rain, and counted in a scintillation counter. Each 
assay was carried out in triplicate or quadruplicate. 
Transfection A~says 
DR-27 and R-1B cells stably expressing human T~R-II tagged with 
FLAG epitope in pRK5 (Chen et al., 1993) (gift of Dr. R. Derynck) or 
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TI~R-I (ALK-5) in pSV7d (Franzen et al., 1993) (gift from Drs. C.-H. 
Heldin and K. Miyazono), respectively, were generated by transfection 
with lipofectin as recommended by the manufacturer (GIBCO-BRL). 
In brief, cells growing in 60 mm dishes were incubated overnight in 
serum-free medium containing 2 p.g of DNA and 10 I~g of lipofectin 
and then washed into media containing 10% FCS and antibiotics. After 
2 days, cells were subcultured into several 75 cm 2 flasks and grown 
in the presence of 25 ~g/ml mycophenolic acid (GIBCO-BRL) for 2-3 
weeks with a change in media every 4-5 days. Mycophenolic acid- 
resistant cells were cloned in microtiter wells by limited dilution in the 
presence of 10% FCS. After 2-3 weeks, each colony was tested for 
sensitivity to the antiproliferative action of TGFJ31, and those growth 
arrested by the cytokine were incubated with [1251]TGFI31 and ascer- 
tained for the prese rice of TI3Rs with the chemical cross-lin ker disuccin- 
imidyl suberate. Transfectants ensitive to TGF~ were continuously 
maintained in hygromycin. In this way, we generated two clones of 
DR-27 cells expressing human TI3R-II (DR27-47 and DR27-50) and six 
clones of R-1B expressing ALK-5 (R1B-TR9, RIB-TR11, RIB-TR16, 
RIB-TR20, RIB-TR22, and RIB-TR25). 
Transient Transfections and Luciferase Assays 
Parental cells were plated to semiconfluency in 6-well tissue culture 
plates, and 24 hr later transfected with lipofectin in serum-free medium 
using 2.0 p.g of reporter plasmid (p3TP-Lux) (gift of Dr. J. Massagu~, 
see Wrana et al., 1992). For DR and R cells, they were transfected 
with 2.0 ~g of p3TP-Lux without and with 0.5 p.g of T~R-II in pcDNA-1 
vector (Lin et al., 1992) or kinase-deficient T~R-II (Chen and Weinberg, 
1995) (gifts from Dr. R. Weinberg) or ALK-5 in pSV7d vector (Franz~n 
et al., 1993), respectively. After overnight incubation at 37°C in a 5% 
COz atmosphere, the medium was replaced with 10% FCS in RPMI 
and incubated for a further 48 hr at 37°C, followed by TGF~, T. cruzi, 
or RPMI extract of T. cruzi and P. falciparum. After 20 hr, cells were 
harvested and assayed for luciferase activity using the luciferase assay 
system described by the manufacturer (Promega). Light emission was 
measured during the initial 30 s of the reaction using a luminometer 
(MONOLIGHT 2010, Analytical Luminescence Laboratory) (courtesy 
of Drs. A. Leiter and A. Kopin). 
For introduction of reporter construct in transfected DR-27 and R-1B 
clones (see above), a procedure similar to the one described above 
was followed, except that the TI3R constructs were ommitted. 
Determination of reporter activity in Mv1Lu cells stably transfected 
with PAl-1 promoter construct (gift from Dr. D. Rifkin) was as described 
by Abe et al. (1994). 
Other Procedures 
Penetrin and trans-sialidase were isolated from T. cruzi by heparin 
affinity chromatography (Herrera et al., 1994) and a combination of 
immunoaffinity and sieving chromatography (Scudder et al., 1993), 
respectively. Cell cycle determination was determined as previously 
described (Ewen et al., 1993). 
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